NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the proposed ...

Shares of FNA opened at $13.03 on Wednesday. Paragon 28 has a 1-year low of $4.65 and a 1-year high of $14.79. The company has a market capitalization of $1.09 billion, a P/E ratio of -17.60 and a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

During the last three months, 5 analysts shared their evaluations of Paragon 28 FNA, revealing diverse outlooks from bullish to bearish. The table below offers a condensed view of their recent ...

Paragon 28, Inc. FNA shares ended the last trading session 8.3% higher at $12.99. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Fintel reports that on January 29, 2025, Needham downgraded their outlook for Paragon 28 (NYSE:FNA) from Buy to Hold. Analyst Price Forecast Suggests 12.46% Upside As of January 29, 2025 ...

Bengaluru: Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand its portfolio of orthopedic surgical devices. The deal will give Zimmer ...

Analyst Price Forecast Suggests 21.83% Upside As of January 29, 2025, the average one-year price target for Paragon 28 is $14.62/share. The forecasts range from a low of $12.12 to a high of $21.00.

Paragon 28 shares rose 8.4% after Zimmer Biomet Holdings agreed to acquire the company. Shares were trading around $13.02. The stock is up about 2.6% over the last year. Zimmer, a medical ...

Zimmer Biomet to acquire Paragon 28 for $13/share, totaling $1.2B in enterprise value. Deal expected to close in H1 2025, with potential $1/share CVR based on 2026 sales milestones. Get real-time ...